{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:51:07Z","timestamp":1791665467423,"version":"4.3.4"},"reference-count":145,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004263","name":"Foundation for Support to Research of Southern Rio Grande State","doi-asserted-by":"publisher","award":["#24\/2551-0001975-8"],"award-info":[{"award-number":["#24\/2551-0001975-8"]}],"id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004263","name":"Foundation for Support to Research of Southern Rio Grande State","doi-asserted-by":"publisher","award":["#24\/2551-0001292-3"],"award-info":[{"award-number":["#24\/2551-0001292-3"]}],"id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordination for the improvement of Higher Education Personnel","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["#444290\/2024-9"],"award-info":[{"award-number":["#444290\/2024-9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["#404221\/2024-6"],"award-info":[{"award-number":["#404221\/2024-6"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.arr.2026.103392","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:46:30Z","timestamp":1791319590000},"page":"103392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A silent RAGE: The inflammatory pathway to dementia in Parkinson\u2019s disease"],"prefix":"10.1016","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2827-5220","authenticated-orcid":false,"given":"Daniel Oppermann","family":"Peixoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2545-7288","authenticated-orcid":false,"given":"Juciano","family":"Gasparotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1543-3004","authenticated-orcid":false,"given":"Olajide Raymond","family":"Ojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2351-2888","authenticated-orcid":false,"given":"Olayemi Philemon","family":"Aro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umin-Awaji Sunday","family":"Godswill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4047-7615","authenticated-orcid":false,"given":"Luiza Franco","family":"de Abreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3480-1078","authenticated-orcid":false,"given":"Luana Carneiro","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Claudio Fonseca","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5254-0509","authenticated-orcid":false,"given":"Daniel Pens","family":"Gelain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2026.103392_bib1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nrneurol.2017.27","article-title":"Cognitive decline in Parkinson disease","volume":"13","author":"Aarsland","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2026.103392_bib2","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/mds.20527","article-title":"A systematic review of prevalence studies of dementia in Parkinson's disease","volume":"20","author":"Aarsland","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2026.103392_bib3","doi-asserted-by":"crossref","DOI":"10.1111\/adb.13333","article-title":"Increased AGE-RAGE axis stress in methamphetamine abuse and methamphetamine-induced psychosis: associations with oxidative stress and increased atherogenicity","volume":"28","author":"Al-Hakeim","year":"2023","journal-title":"Addict. Biol."},{"key":"10.1016\/j.arr.2026.103392_bib4","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1212\/WNL.0000000000000425","article-title":"CSF A\u03b242 predicts early-onset dementia in Parkinson disease","volume":"82","author":"Alves","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2026.103392_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.570586","article-title":"Functions of p38 MAP Kinases in the Central Nervous System","volume":"13","author":"Asih","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.arr.2026.103392_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.635636","article-title":"The p38(MAPK)-MK2 Signaling Axis as a Critical Link Between Inflammation and Synaptic Transmission","volume":"9","author":"Beamer","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.arr.2026.103392_bib7","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson's disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.arr.2026.103392_bib8","first-page":"S281","article-title":"Brain-first versus gut-first parkinson's disease: a hypothesis","volume":"9","author":"Borghammer","year":"2019","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.arr.2026.103392_bib9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.14283\/jpad.2018.18","article-title":"Development of azeliragon, an oral small molecule antagonist of the receptor for advanced glycation endproducts, for the potential slowing of loss of cognition in mild alzheimer's disease","volume":"5","author":"Burstein","year":"2018","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.arr.2026.103392_bib10","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1161\/HYPERTENSIONAHA.112.195511","article-title":"Hypertension induces brain \u03b2-amyloid accumulation, cognitive impairment, and memory deterioration through activation of receptor for advanced glycation end products in brain vasculature","volume":"60","author":"Carnevale","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.arr.2026.103392_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2013.10.056","article-title":"A\u03b2-AGE aggravates cognitive deficit in rats via RAGE pathway","volume":"257","author":"Chen","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.arr.2026.103392_bib12","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1172\/JCI25247","article-title":"P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model","volume":"115","author":"Cirrito","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.arr.2026.103392_bib13","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1136\/jnnp.74.7.852","article-title":"Lewy body cortical involvement may not always predict dementia in Parkinson's disease","volume":"74","author":"Colosimo","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2026.103392_bib14","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1002\/mds.22594","article-title":"Cerebrospinal tau, phospho-tau, and beta-amyloid and neuropsychological functions in Parkinson's disease","volume":"24","author":"Compta","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2026.103392_bib15","doi-asserted-by":"crossref","unstructured":"Compta, Y., Parkkinen, L., O'Sullivan, S.S., Vandrovcova, J., Holton, J.L., Collins, C., Lashley, T., Kallis, C., Williams, D.R., de Silva, R., Lees, A.J., Revesz, T., 2011. Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?. https:\/\/doi.org\/10.1093\/brain\/awr031.","DOI":"10.1093\/brain\/awr031"},{"key":"10.1016\/j.arr.2026.103392_bib16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jns.2010.08.029","article-title":"Oxidative stress in Alzheimer's disease hippocampus: a topographical study","volume":"299","author":"Cruz-S\u00e1nchez","year":"2010","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.arr.2026.103392_bib17","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s10571-024-01491-4","article-title":"Cerebral Hypoxia-Induced Molecular Alterations and Their Impact on the Physiology of Neurons and Dendritic Spines: A Comprehensive Review","volume":"44","author":"Cui","year":"2024","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.arr.2026.103392_bib18","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.biopsych.2008.07.024","article-title":"Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease","volume":"65","author":"Cunningham","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.arr.2026.103392_bib19","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/01.jnen.0000179050.54522.5a","article-title":"Evidence of oxidative stress in the neocortex in incidental Lewy body disease","volume":"64","author":"Dalfo","year":"2005","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.arr.2026.103392_bib20","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nm890","article-title":"RAGE mediates amyloid-\u03b2 peptide transport across the blood-brain barrier and accumulation in brain","volume":"9","author":"Deane","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2026.103392_bib21","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1172\/JCI58642","article-title":"A multimodal RAGE-specific inhibitor reduces amyloid beta-mediated brain disorder in a mouse model of Alzheimer disease","volume":"122","author":"Deane","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.arr.2026.103392_bib22","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neuron.2004.07.017","article-title":"LRP\/amyloid \u03b2-peptide interaction mediates differential brain efflux of A\u03b2 isoforms","volume":"43","author":"Deane","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2026.103392_bib23","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.immuni.2018.08.016","article-title":"The endotoxin delivery protein HMGB1 mediates caspase-11-dependent lethality in sepsis","volume":"49","author":"Deng","year":"2018","journal-title":"J. Immun."},{"key":"10.1016\/j.arr.2026.103392_bib24","doi-asserted-by":"crossref","DOI":"10.4172\/2161-0460.1000421","article-title":"The Receptor for Advanced Glycation Endproducts (RAGE) and Mediation of Inflammatory Neurodegeneration","author":"Derk","year":"2018","journal-title":"J. Alzheimers Dis. Park. 8."},{"key":"10.1016\/j.arr.2026.103392_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2025.115034","article-title":"Sex differences distinguish performance in four object recognition-based memory tasks in the Pink1-\/- rat model of Parkinson's disease","volume":"300","author":"Desai","year":"2025","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.arr.2026.103392_bib26","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00401-006-0115-3","article-title":"RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease","volume":"112","author":"Donahue","year":"2006","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2026.103392_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.931473","article-title":"Pathophysiology of RAGE in inflammatory diseases","volume":"13","author":"Dong","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.arr.2026.103392_bib28","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1001\/archneur.62.11.1734","article-title":"Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia","volume":"62","author":"Emanuele","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.arr.2026.103392_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101958","article-title":"The use of the soluble receptor for advanced glycation-end products (sRAGE) as a potential biomarker of disease risk and adverse outcomes","volume":"42","author":"Erusalimsky","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.arr.2026.103392_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2025.115662","article-title":"HMGB1\/RAGE signaling mediates the activation of microglia and participates in depressive-like behaviors and cognitive deficits in rats after ischemia-reperfusion","volume":"492","author":"Fan","year":"2025","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.arr.2026.103392_bib31","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1096\/fj.09-139634","article-title":"RAGE-dependent signaling in microglia contributes to neuroinflammation, Abeta accumulation, and impaired learning\/memory in a mouse model of Alzheimer's disease","volume":"24","author":"Fang","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.arr.2026.103392_bib32","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1093\/ije\/dys052","article-title":"CNS infections, sepsis and risk of Parkinson's disease","volume":"41","author":"Fang","year":"2012","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.arr.2026.103392_bib33","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bbi.2015.10.009","article-title":"The redox state of the alarmin HMGB1 is a pivotal factor in neuroinflammatory and microglial priming: A role for the NLRP3 inflammasome","volume":"55","author":"Frank","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.arr.2026.103392_bib34","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/2061376","article-title":"Metabolic derangements contribute to reduced sRAGE isoforms in subjects with Alzheimer's disease","volume":"2018","author":"Fuller","year":"2018","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.arr.2026.103392_bib35","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1212\/WNL.0000000000000364","article-title":"Clinical trial of an inhibitor of RAGE-Abeta interactions in Alzheimer disease","volume":"82","author":"Galasko","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2026.103392_bib36","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12974-025-03489-1","article-title":"Targeting the RAGE\u2013RIPK1 binding site attenuates diabetes-associated cognitive deficits","volume":"22","author":"Gao","year":"2025","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.arr.2026.103392_bib37","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/ana.24396","article-title":"Traumatic brain injury in later life increases risk for Parkinson disease","volume":"77","author":"Gardner","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2026.103392_bib38","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1074\/jbc.M117.786756","article-title":"Receptor for advanced glycation end products mediates sepsis-triggered amyloid-beta accumulation, Tau phosphorylation, and cognitive impairment","volume":"293","author":"Gasparotto","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2026.103392_bib39","doi-asserted-by":"crossref","first-page":"8795","DOI":"10.1038\/s41598-017-09257-3","article-title":"Targeted inhibition of RAGE in substantia nigra of rats blocks 6-OHDA-induced dopaminergic denervation","volume":"7","author":"Gasparotto","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2026.103392_bib40","first-page":"717","article-title":"RAGE Against the Glycation Machine in Synucleinopathies: Time to Explore New Questions","volume":"13","author":"Gelain","year":"2023","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.arr.2026.103392_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2021.113652","article-title":"A review of behavioral methods for the evaluation of cognitive performance in animal models: Current techniques and links to human cognition","volume":"244","author":"Ghafarimoghadam","year":"2022","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.arr.2026.103392_bib42","first-page":"T260","article-title":"Decreased plasma levels of soluble receptor for advanced glycation end products in mild cognitive impairment","volume":"4","author":"Ghidoni","year":"2008","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103392_bib43","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0002-9440(10)61723-3","article-title":"Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice","volume":"159","author":"Goova","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.arr.2026.103392_bib44","doi-asserted-by":"crossref","first-page":"196. e13","DOI":"10.1016\/j.neurobiolaging.2010.05.026","article-title":"AGEs\/RAGE complex upregulates BACE1 via NF-\u03baB pathway activation","volume":"33","author":"Guglielmotto","year":"2012","journal-title":"Neurobiol. Aging"},{"issue":"S1","key":"10.1016\/j.arr.2026.103392_bib45","doi-asserted-by":"crossref","first-page":"S611","DOI":"10.3233\/JAD-179935","article-title":"Role of Amyloid-\u03b2 and Tau Proteins in Alzheimer's Disease: Confuting the Amyloid Cascade","volume":"64","author":"Gulisano","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2026.103392_bib46","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jns.2017.01.012","article-title":"Dementia in Parkinson's disease","volume":"374","author":"Hanagasi","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.arr.2026.103392_bib47","article-title":"Structural Neuroimaging Markers of Cognitive Decline in Parkinson's Disease","volume":"2016","author":"Hanganu","year":"2016","journal-title":"Park. Dis."},{"key":"10.1016\/j.arr.2026.103392_bib48","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0092-8674(00)80801-6","article-title":"RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100\/calgranulin polypeptides","volume":"97","author":"Hofmann","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.arr.2026.103392_bib49","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1474-4422(23)00404-0","article-title":"A biological classification of Parkinson's disease: the SynNeurGe research diagnostic criteria","volume":"23","author":"H\u00f6glinger","year":"2024","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2026.103392_bib50","doi-asserted-by":"crossref","first-page":"25752","DOI":"10.1074\/jbc.270.43.25752","article-title":"The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system","volume":"270","author":"Hori","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2026.103392_bib51","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3389\/fneur.2018.00162","article-title":"Hypertension and Diagnosis of Parkinson's Disease: A Meta-Analysis of Cohort Studies","volume":"9","author":"Hou","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.arr.2026.103392_bib52","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3389\/fgene.2018.00540","article-title":"Influence of ADAM10 polymorphisms on plasma level of soluble receptor for advanced glycation end products and the association with Alzheimer's disease risk","volume":"9","author":"Huang","year":"2018","journal-title":"Front. Genet."},{"key":"10.1016\/j.arr.2026.103392_bib53","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00401-018-1907-y","article-title":"Picomolar concentrations of oligomeric alpha-synuclein sensitizes TLR4 to play an initiating role in Parkinson's disease pathogenesis","volume":"137","author":"Hughes","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2026.103392_bib54","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003748","article-title":"A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2","volume":"4","author":"Iliff","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.arr.2026.103392_bib55","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.nbd.2013.03.006","article-title":"Receptor for Advanced Glycation Endproducts is upregulated in temporal lobe epilepsy and contributes to experimental seizures","volume":"58","author":"Iori","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2026.103392_bib56","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nrn3549","article-title":"Parkinson's disease dementia: convergence of \u03b1-synuclein, tau and amyloid-\u03b2 pathologies","volume":"14","author":"Irwin","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.arr.2026.103392_bib57","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3390\/ijms25010498","article-title":"Pathobiology of Cognitive Impairment in Parkinson Disease: Challenges and Outlooks","volume":"25","author":"Jellinger","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2026.103392_bib58","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.biopsych.2022.10.015","article-title":"Pathogenic role of RAGE in tau transmission and memory deficits","volume":"93","author":"Kim","year":"2023","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.arr.2026.103392_bib59","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.neurobiolaging.2006.06.019","article-title":"Intracellular A\u03b2 and cognitive deficits precede \u03b2-amyloid deposition in transgenic arcA\u03b2 mice","volume":"28","author":"Knobloch","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2026.103392_bib60","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2174\/1570159X20666220922153903","article-title":"Receptors for Advanced Glycation End Products (RAGE): Promising Targets Aiming at the Treatment of Neurodegenerative Conditions","volume":"21","author":"Koerich","year":"2023","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.arr.2026.103392_bib61","doi-asserted-by":"crossref","DOI":"10.4161\/tisb.23993","article-title":"Disruption of blood-brain barrier in Alzheimer disease pathogenesis","volume":"1","author":"Kook","year":"2013","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.arr.2026.103392_bib62","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1007\/s00429-014-0785-x","article-title":"Imaging changes associated with cognitive abnormalities in Parkinson's disease","volume":"220","author":"Koshimori","year":"2015","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.arr.2026.103392_bib63","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3389\/fneur.2018.00824","article-title":"Differential Gray Matter Vulnerability in the 1 Year Following a Clinically Isolated Syndrome","volume":"9","author":"Koubiyr","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.arr.2026.103392_bib64","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11910-019-1006-z","article-title":"Gray Matter Changes in Parkinson's and Alzheimer's Disease and Relation to Cognition","volume":"19","author":"Krajcovicova","year":"2019","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.arr.2026.103392_bib65","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.neurobiolaging.2014.09.025","article-title":"Advanced glycation end products are mitogenic signals and trigger cell cycle reentry of neurons in Alzheimer's disease brain","volume":"36","author":"Kuhla","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2026.103392_bib66","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s10548-018-0675-2","article-title":"Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition","volume":"32","author":"Kunst","year":"2019","journal-title":"Brain Topogr."},{"key":"10.1016\/j.arr.2026.103392_bib67","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40035-024-00430-z","article-title":"Blood-brain barrier alterations and their impact on Parkinson's disease pathogenesis and therapy","volume":"13","author":"Lau","year":"2024","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.arr.2026.103392_bib68","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.parkreldis.2020.11.011","article-title":"Increased microglial activation in patients with Parkinson disease using [18F]-DPA714 TSPO PET imaging","volume":"82","author":"Lavisse","year":"2021","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.arr.2026.103392_bib69","doi-asserted-by":"crossref","first-page":"114","DOI":"10.15283\/ijsc18110","article-title":"CRISPR\/Cas9 Edited sRAGE-MSCs Protect Neuronal Death in Parkinsons Disease Model","volume":"12","author":"Lee","year":"2019","journal-title":"Int. J. Stem. Cells"},{"key":"10.1016\/j.arr.2026.103392_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2025.115540","article-title":"RAGE\/AP-1\/OTR signaling pathway in rat hippocampus DG involved in CUS induced depressive-like behaviors","volume":"485","author":"Li","year":"2025","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.arr.2026.103392_bib71","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jocn.2012.06.005","article-title":"Decreased plasma levels of soluble low density lipoprotein receptor-related protein-1 (sLRP) and the soluble form of the receptor for advanced glycation end products (sRAGE) in the clinical diagnosis of Alzheimer's disease","volume":"20","author":"Liang","year":"2013","journal-title":"J. Clin. Neurosc."},{"key":"10.1016\/j.arr.2026.103392_bib72","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1172\/JCI200418704","article-title":"Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response","volume":"113","author":"Liliensiek","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.arr.2026.103392_bib73","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1007\/s00415-018-9100-8","article-title":"Amyloid-\u03b2 and Parkinson's disease","volume":"266","author":"Lim","year":"2019","journal-title":"J. Neurol."},{"key":"10.1016\/j.arr.2026.103392_bib74","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1002\/mds.23823","article-title":"MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI","volume":"26","author":"Litvan","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2026.103392_bib75","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/mds.24893","article-title":"Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines","volume":"27","author":"Litvan","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2026.103392_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111401","article-title":"Interaction of RAGE with alpha-synuclein fibrils mediates inflammatory response of microglia","volume":"40","author":"Long","year":"2022","journal-title":"Cell. Rep."},{"key":"10.1016\/j.arr.2026.103392_bib77","first-page":"1117","article-title":"Serum Neurofilament Dynamics Predicts Cognitive Progression in de novo Parkinson's Disease","volume":"11","author":"Ma","year":"2021","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.arr.2026.103392_bib78","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.2174\/0115680266320808240709061445","article-title":"The General Neurocognitive Decline in Patients with Methamphetamine Use and Transient Methamphetamine-induced Psychosis is Primarily Determined by Oxidative and AGE-RAGE Stress","volume":"24","author":"Maes","year":"2024","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.arr.2026.103392_bib79","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41531-024-00823-x","article-title":"Biomarkers for cognitive impairment in alpha-synucleinopathies: an overview of systematic reviews and meta-analyses","volume":"10","author":"Mantovani","year":"2024","journal-title":"NPJ Park. Dis."},{"key":"10.1016\/j.arr.2026.103392_bib80","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.expneurol.2011.08.012","article-title":"High-mobility group box-1 impairs memory in mice through both toll-like receptor 4 and Receptor for Advanced Glycation End Products","volume":"232","author":"Mazarati","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.arr.2026.103392_bib81","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.mcn.2010.06.005","article-title":"A novel role for the Receptor for Advanced Glycation End-products in neural progenitor cells derived from adult SubVentricular Zone","volume":"45","author":"Meneghini","year":"2010","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.arr.2026.103392_bib82","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.brainres.2008.06.124","article-title":"Hippocampal RAGE immunoreactivity in early and advanced Alzheimer's disease","volume":"1230","author":"Miller","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.arr.2026.103392_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2020.113255","article-title":"RAGE signaling is required for AMPA receptor dysfunction in the hippocampus of hyperglycemic mice","volume":"229","author":"Momeni","year":"2021","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.arr.2026.103392_bib84","doi-asserted-by":"crossref","first-page":"12023","DOI":"10.1523\/JNEUROSCI.2435-08.2008","article-title":"The HMGB1 receptor RAGE mediates ischemic brain damage","volume":"28","author":"Muhammad","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2026.103392_bib85","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0891-0618(00)00096-X","article-title":"Crosslinking of \u03b1-synuclein by advanced glycation endproducts\u2014an early pathophysiological step in Lewy body formation?","volume":"20","author":"M\u00fcnch","year":"2000","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.arr.2026.103392_bib86","doi-asserted-by":"crossref","DOI":"10.1111\/eci.14232","article-title":"Soluble receptor of advanced glycation end product as a biomarker in neurocognitive and neuropsychiatric disorders: A meta-analysis of controlled studies","volume":"54","author":"Nameni","year":"2024","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.arr.2026.103392_bib87","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.neurobiolaging.2014.07.005","article-title":"Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies","volume":"36","author":"Nedelska","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2026.103392_bib88","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41531-021-00202-w","article-title":"Case-control study of hypertension and Parkinson's disease","volume":"7","author":"Ng","year":"2021","journal-title":"NPJ Park. Dis."},{"key":"10.1016\/j.arr.2026.103392_bib89","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/MIB.0000000000000667","article-title":"Enteric Glial Cells: A New Frontier in Neurogastroenterology and Clinical Target for Inflammatory Bowel Diseases","volume":"22","author":"Ochoa-Cortes","year":"2016","journal-title":"Inflamm. Bowel. Dis."},{"key":"10.1016\/j.arr.2026.103392_bib90","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neuropharm.2014.05.007","article-title":"Glycyrrhizin inhibits traumatic brain injury by reducing HMGB1-RAGE interaction","volume":"85","author":"Okuma","year":"2014","journal-title":"Neuropharmacol"},{"key":"10.1016\/j.arr.2026.103392_bib91","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1586\/ern.09.107","article-title":"MAPK, \u03b2-amyloid and synaptic dysfunction: the role of RAGE","volume":"9","author":"Origlia","year":"2009","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.arr.2026.103392_bib92","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3233\/JAD-2009-1045","article-title":"A\u03b2-dependent Inhibition of LTP in different intracortical circuits of the visual cortex: the role of RAGE","volume":"17","author":"Origlia","year":"2009","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.arr.2026.103392_bib93","doi-asserted-by":"crossref","first-page":"8749","DOI":"10.1523\/JNEUROSCI.0141-14.2014","article-title":"RAGE inhibition in microglia prevents ischemia-dependent synaptic dysfunction in an amyloid-enriched environment","volume":"34","author":"Origlia","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2026.103392_bib94","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1523\/JNEUROSCI.0204-08.2008","article-title":"Receptor for advanced glycation end product-dependent activation of p38 mitogen-activated protein kinase contributes to amyloid-beta-mediated cortical synaptic dysfunction","volume":"28","author":"Origlia","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2026.103392_bib95","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3389\/fnagi.2020.00156","article-title":"Increased Cerebrospinal Fluid S100B and NSE Reflect Neuronal and Glial Damage in Parkinson's Disease","volume":"12","author":"Papu\u0107","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2026.103392_bib96","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ana.20321","article-title":"\u03b1-synuclein pathology does not predict extrapyramidal symptoms or dementia","volume":"57","author":"Parkkinen","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2026.103392_bib97","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.3390\/ijms21134609","article-title":"HMGB1-mediated neuroinflammatory responses in brain injuries: potential mechanisms and therapeutic opportunities","volume":"21","author":"Paudel","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2026.103392_bib98","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1111\/jnc.15956","article-title":"Increased alpha-synuclein and neuroinflammation in the substantia nigra triggered by systemic inflammation are reversed by targeted inhibition of the receptor for advanced glycation end products (RAGE)","volume":"168","author":"Peixoto","year":"2024","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2026.103392_bib99","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nrneurol.2014.38","article-title":"Microglial priming in neurodegenerative disease","volume":"10","author":"Perry","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2026.103392_bib100","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrneurol.2010.17","article-title":"Microglia in neurodegenerative disease","volume":"6","author":"Perry","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2026.103392_bib101","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019567","article-title":"Olfactory and visuospatial learning and memory performance in two strains of Alzheimer's disease model mice--a longitudinal study","volume":"6","author":"Phillips","year":"2011","journal-title":"PLoS. One"},{"key":"10.1016\/j.arr.2026.103392_bib102","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9348651","article-title":"RAGE expression and ROS generation in neurons: differentiation versus damage","volume":"2016","author":"Piras","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.arr.2026.103392_bib103","doi-asserted-by":"crossref","first-page":"15659","DOI":"10.1096\/fj.202002136R","article-title":"The role of RAGE in host pathology and crosstalk between RAGE and TLR4 in innate immune signal transduction pathways","volume":"34","author":"Prantner","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.arr.2026.103392_bib104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1179\/1743132812Y.0000000118","article-title":"A review of methods used to study cognitive deficits in Parkinson's disease","volume":"35","author":"Rana","year":"2013","journal-title":"Neurol. Res."},{"key":"10.1016\/j.arr.2026.103392_bib105","first-page":"183","article-title":"Progression of Cognitive Decline in Parkinson's Disease","volume":"8","author":"Roheger","year":"2018","journal-title":"J. Park. 's. Dis."},{"key":"10.1016\/j.arr.2026.103392_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102863","article-title":"Enteric glia in homeostasis and disease: From fundamental biology to human pathology","volume":"24","author":"Rosenberg","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.arr.2026.103392_bib107","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/WAD.0b013e31819c5ef4","article-title":"Parkinson disease with dementia: comparing patients with and without Alzheimer pathology","volume":"23","author":"Sabbagh","year":"2009","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.arr.2026.103392_bib108","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/WAD.0b013e318204b550","article-title":"PF-04494700, an oral inhibitor of receptor for advanced glycation end products (RAGE), in Alzheimer disease","volume":"25","author":"Sabbagh","year":"2011","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.arr.2026.103392_bib109","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/nrneurol.2014.181","article-title":"Classifying neurocognitive disorders: the DSM-5 approach","volume":"10","author":"Sachdev","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2026.103392_bib110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008309","article-title":"Deletion of RAGE causes hyperactivity and increased sensitivity to auditory stimuli in mice","volume":"4","author":"Sakatani","year":"2009","journal-title":"PLoS. One"},{"key":"10.1016\/j.arr.2026.103392_bib111","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.nbd.2016.02.018","article-title":"In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson's disease which can be attenuated by glycyrrhizin","volume":"91","author":"Santoro","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2026.103392_bib112","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.nbd.2019.02.023","article-title":"An increased rate of longitudinal cognitive decline is observed in Parkinson's disease patients with low CSF A\u03b242 and an APOE \u03b54 allele","volume":"127","author":"Shahid","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2026.103392_bib113","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s12031-016-0837-1","article-title":"Translational Assays for Assessment of Cognition in Rodent Models of Alzheimer's Disease and Dementia","volume":"60","author":"Shepherd","year":"2016","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.arr.2026.103392_bib114","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.bbr.2017.01.012","article-title":"Anti-RAGE antibody attenuates isoflurane-induced cognitive dysfunction in aged rats","volume":"322","author":"Shi","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.arr.2026.103392_bib115","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.1750-3639.2009.00368.x","article-title":"Neuroimaging and cognition in Parkinson's disease dementia","volume":"20","author":"Silbert","year":"2010","journal-title":"Brain Pathol."},{"key":"10.1016\/j.arr.2026.103392_bib116","first-page":"1234","article-title":"Neuropathology of dementia in patients with Parkinson's disease: a systematic review of autopsy studies","volume":"90","author":"Smith","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2026.103392_bib117","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1159\/000480213","article-title":"Extracellular HSP70 Activates ERK1\/2, NF-kappa B and Pro-Inflammatory Gene Transcription Through Binding with RAGE in A549 Human Lung Cancer Cells","volume":"42","author":"Somensi","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.arr.2026.103392_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2025.111096","article-title":"Early-stage Parkinson's disease detection using multimodal brain-body biomarkers from fNIRS and IMU data","volume":"197","author":"Sousani","year":"2025","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.arr.2026.103392_bib119","doi-asserted-by":"crossref","first-page":"249","DOI":"10.31887\/DCNS.2019.21.3\/mrossner","article-title":"Assessing behavior and cognition in rodents, nonhuman primates, and humans: where are the limits of translation?","volume":"21","author":"Stephan","year":"2019","journal-title":"Dialog.-. Clin. Neurosci."},{"key":"10.1016\/j.arr.2026.103392_bib120","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bbi.2018.07.017","article-title":"The concerted amyloid-beta clearance of LRP1 and ABCB1\/P-gp across the blood-brain barrier is linked by PICALM","volume":"73","author":"Storck","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.arr.2026.103392_bib121","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004092","article-title":"Hospital-treated infections in early- and mid-life and risk of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis: A nationwide nested case-control study in Sweden","volume":"19","author":"Sun","year":"2022","journal-title":"PLoS. Med."},{"key":"10.1016\/j.arr.2026.103392_bib122","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/ana.24448","article-title":"Vagotomy and subsequent risk of Parkinson's disease","volume":"78","author":"Svensson","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2026.103392_bib123","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","article-title":"Clearance systems in the brain-implications for Alzheimer disease","volume":"11","author":"Tarasoff-Conway","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2026.103392_bib124","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/imr.13419","article-title":"The impact of neuroinflammation on neuronal integrity","volume":"327","author":"Tastan","year":"2024","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.arr.2026.103392_bib125","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41531-025-01159-w","article-title":"Glycation of alpha-synuclein enhances aggregation and neuroinflammatory responses","volume":"11","author":"Vasili","year":"2025","journal-title":"NPJ Park. Dis."},{"key":"10.1016\/j.arr.2026.103392_bib126","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/mds.26566","article-title":"Glycation in Parkinson's disease and Alzheimer's disease","volume":"31","author":"Vicente Miranda","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2026.103392_bib127","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1093\/brain\/awx056","article-title":"Glycation potentiates alpha-synuclein-associated neurodegeneration in synucleinopathies","volume":"140","author":"Vicente Miranda","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.arr.2026.103392_bib128","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000261723","article-title":"RAGE does not affect amyloid pathology in transgenic ArcA\u03b2 mice","volume":"6","author":"Vodopivec","year":"2009","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.arr.2026.103392_bib129","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.3233\/JAD-170483","article-title":"Synthetic Fragment of Receptor for Advanced Glycation End Products Prevents Memory Loss and Protects Brain Neurons in Olfactory Bulbectomized Mice","volume":"61","author":"Volpina","year":"2018","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.arr.2026.103392_bib130","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fgene.2014.00088","article-title":"Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models","volume":"5","author":"Webster","year":"2014","journal-title":"Front. Genet."},{"key":"10.1016\/j.arr.2026.103392_bib131","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/jnnp-2013-305277","article-title":"The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort","volume":"84","author":"Williams-Gray","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2026.103392_bib132","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1001\/jamaneurol.2017.3713","article-title":"Associations Between Tau, \u03b2-Amyloid, and Cognition in Parkinson Disease","volume":"75","author":"Winer","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2026.103392_bib133","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.cpet.2017.02.005","article-title":"Multimodal PET Imaging of Amyloid and Tau Pathology in Alzheimer Disease and Non-Alzheimer Disease Dementias","volume":"12","author":"Xia","year":"2017","journal-title":"PET Clin."},{"key":"10.1016\/j.arr.2026.103392_bib134","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.4049\/jimmunol.1002253","article-title":"Septic shock is associated with receptor for advanced glycation end products ligation of LPS","volume":"186","author":"Yamamoto","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.arr.2026.103392_bib135","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s42003-019-0325-6","article-title":"Vascular RAGE transports oxytocin into the brain to elicit its maternal bonding behaviour in mice","volume":"2","author":"Yamamoto","year":"2019","journal-title":"Commun. Biol."},{"key":"10.1016\/j.arr.2026.103392_bib136","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/382685a0","article-title":"RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease","volume":"382","author":"Yan","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.arr.2026.103392_bib137","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.brainresbull.2020.06.020","article-title":"RAGE Signaling pathway in hippocampus dentate gyrus involved in GLT-1 decrease induced by chronic unpredictable stress in rats","volume":"163","author":"Yang","year":"2020","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.arr.2026.103392_bib138","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3389\/fimmu.2020.00484","article-title":"Targeting Inflammation Driven by HMGB1","volume":"11","author":"Yang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.arr.2026.103392_bib139","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1084\/jem.20141318","article-title":"MD-2 is required for disulfide HMGB1-dependent TLR4 signaling","volume":"212","author":"Yang","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.arr.2026.103392_bib140","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.bbi.2023.12.022","article-title":"RAGE in circulating immune cells is fundamental for hippocampal inflammation and cognitive decline in a mouse model of latent chronic inflammation","volume":"116","author":"Ye","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.arr.2026.103392_bib141","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1007\/s00018-009-0121-4","article-title":"Ectodomain shedding of the receptor for advanced glycation end products: a novel therapeutic target for Alzheimer's disease","volume":"66","author":"Zhang","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.arr.2026.103392_bib142","doi-asserted-by":"crossref","first-page":"28282","DOI":"10.1021\/jacs.4c08869","article-title":"Inhibitor Development for \u03b1-Synuclein Fibril's Disordered Region to Alleviate Parkinson's Disease Pathology","volume":"146","author":"Zhang","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.arr.2026.103392_bib143","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/nn.4025","article-title":"Central role for PICALM in amyloid-\u03b2 blood-brain barrier transcytosis and clearance","volume":"18","author":"Zhao","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.arr.2026.103392_bib144","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14449","article-title":"Binding of RAGE and RIPK1 induces cognitive deficits in chronic hyperglycemia-derived neuroinflammation","volume":"30","author":"Zhou","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.arr.2026.103392_bib145","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1160\/TH15-11-0898","article-title":"Endothelial RAGE exacerbates acute postischaemic cardiac inflammation","volume":"116","author":"Ziegler","year":"2016","journal-title":"Thromb. Haemost."}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163726003843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163726003843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:18:03Z","timestamp":1791663483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163726003843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":145,"alternative-id":["S1568163726003843"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2026.103392","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A silent RAGE: The inflammatory pathway to dementia in Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2026.103392","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103392"}}